News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Active Biotech AB (BTPC)'s Project ANYARA Will Be Presented at the European Cancer Congress 2013


9/12/2013 9:37:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Lund (Sweden), September 12, 2013. Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced that a biomarker trend analysis of overall survival (OS) and Progression Free Survival (PFS) from the ANYARA Phase II/III study in renal cell cancer will be presented at the scientific conference "European Cancer Congress 2013" (ECCO-ESMO-ESTRO) held in Amsterdam, the Netherlands, September 27 - October 1.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES